References
- Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80. https://doi.org/10.1056/NEJMoa012843
- Kounis NG, Kounis GN, Soufras GD. Kounis syndrome: a potential cause of simultaneous multivessel coronary spasm and thrombosis after drug-eluting stent implantation. J Invasive Cardiol 2007;19:200-1.
- Tomassini F, Varbella F, Gagnor A, Infantino V, Luceri S, Conte MR. Severe multivessel coronary spasm after sirolimus-eluting stent implantation. J Cardiovasc Med (Hagerstown) 2009;10:485-8. https://doi.org/10.2459/JCM.0b013e32831daf84
- Brott BC, Anayiotos AS, Chapman GD, Anderson PG, Hillegass WB. Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol 2006;18:584-92.
- Togni M, Eberli FR. Vasoconstriction and coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol 2006;18:593.
- Kim JW, Park CG, Seo HS, Oh DJ. Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation. Heart 2005; 91:e15. https://doi.org/10.1136/hrt.2004.049932
- Butt M, Connolly D, Lip GY. Drug-eluting stents: a comprehensive appraisal. Future Cardiol 2009;5:141-57. https://doi.org/10.2217/14796678.5.2.141
- Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46:231-6. https://doi.org/10.1016/j.jacc.2005.01.062
- Tan W, Cheng KL, Chen QX. Hypersensitivity to drug-eluting stent and stent thrombosis: Kounis or not Kounis syndrome? Chin Med J (Engl) 2009;122:2390-3.
- Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-93. https://doi.org/10.1161/hc3601.093987
- Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol 2009;57:567-84.
- Koh KK, Moon TH, Song JH, et al. Comparison of clinical and laboratory findings between patients with diffuse three-vessel coronary artery spasm and other types of coronary artery spasm. Cathet Cardiovasc Diagn 1996;37:132-9. https://doi.org/10.1002/(SICI)1097-0304(199602)37:2<132::AID-CCD6>3.0.CO;2-E
- Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9. https://doi.org/10.1161/01.CIR.87.1.76
- Park YM, Han SH, Ko KP, et al. Diffuse multi-vessel coronary artery spasm: incidence and clinical prognosis. Int J Cardiol 2012 [Epub ahead of print].
- Chuang YT, Ueng KC. Spontaneous and simultaneous multivessel coronary spasm causing multisite myocardial infarction, cardiogenic shock, atrioventricular block, and ventricular fibrillation. Circ J 2009;73: 1961-4. https://doi.org/10.1253/circj.CJ-08-0589
- Kusama Y, Kodani E, Nakagomi A, et al. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. J Nihon Med Sch 2011;78:4-12. https://doi.org/10.1272/jnms.78.4
- Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 1989;79:597-602. https://doi.org/10.1161/01.CIR.79.3.597
- Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000;118:1690-5. https://doi.org/10.1378/chest.118.6.1690
- Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32:1672-9. https://doi.org/10.1016/S0735-1097(98)00447-1
- Yasue H, Mizuno Y, Harada E, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008; 51:1742-8. https://doi.org/10.1016/j.jacc.2007.12.049
- Park YM, Kang WC, Shin KC, et al. Repeated sudden cardiac death in coronary spasm: is IVUS helpful to decide treatment strategy? Int J Cardiol 2012;154:e57-9. https://doi.org/10.1016/j.ijcard.2011.06.034
- Kwon TG, Bae JH, Jeong MH, et al. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009;133:173-8. https://doi.org/10.1016/j.ijcard.2007.12.022
- Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-81. https://doi.org/10.1016/j.jacc.2005.07.071
- Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52:333-42. https://doi.org/10.1016/j.jacc.2008.04.030
- Sarno G, Lagerqvist B, Carlsson J, et al. Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Int J Cardiol 2012 [Epub ahead of print].
Cited by
- Zotarolimus : Multi-vessel coronary spasm: case report vol.1446, pp.1, 2013, https://doi.org/10.1007/s40278-013-2360-2
- Coronary vasomotion dysfunction after everolimus-eluting stent implantation vol.6, pp.4, 2013, https://doi.org/10.1556/imas.6.2014.4.6
- Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature vol.7, pp.4, 2016, https://doi.org/10.7150/jca.13611